Results 741-760 of 8,245 for speaker:Bríd Smith

Joint Oireachtas Committee on Health: Legalisation of Medicinal Cannabis: Discussion (24 Nov 2016)

Bríd Smith: I just want to be clear. Dr. Doherty said he is in favour of getting CBD and THC over the line to start using it and then he can monitor it.

Joint Oireachtas Committee on Health: Legalisation of Medicinal Cannabis: Discussion (24 Nov 2016)

Bríd Smith: Yes, the evidence that the authority is looking for that will get it over the initial hurdle is evidence that it works not evidence that it does this, that or the other following long-term use.

Joint Oireachtas Committee on Health: Legalisation of Medicinal Cannabis: Discussion (24 Nov 2016)

Bríd Smith: That it actually works.

Joint Oireachtas Committee on Health: Legalisation of Medicinal Cannabis: Discussion (24 Nov 2016)

Bríd Smith: I expect they carry that risk with the drugs they are being administered at the moment anyway.

Ceisteanna - Questions: National Risk Assessment (29 Nov 2016)

Bríd Smith: 2. To ask the Taoiseach his views on whether the election of Donald Trump means he should revise his strategic risk assessments plan. [36055/16]

Ceisteanna - Questions: National Risk Assessment (29 Nov 2016)

Bríd Smith: I know the Taoiseach does not have a crystal ball. None of us has a crystal ball. As we have heard, the draft national risk assessment plan covers some key areas for us. I want to draw the Taoiseach's attention to two areas that are relevant following the election of Donald Trump. There are global concerns about the President-elect's attitude to the issue of climate change in the context...

Written Answers — Department of Arts, Heritage and the Gaeltacht: Historical Records (29 Nov 2016)

Bríd Smith: 34. To ask the Minister for Arts, Heritage and the Gaeltacht her views on the proposed sale of a letter from Pádraig Pearse; and if she will make a statement on the matter. [37213/16]

Written Answers — Department of Arts, Heritage and the Gaeltacht: Hare Coursing (29 Nov 2016)

Bríd Smith: 62. To ask the Minister for Arts, Heritage and the Gaeltacht if her attention has been drawn to recent evidence that suggests her previous statements that hare coursing was well regulated and avoided any harm to hares were mistaken; and if she will make a statement on the matter. [37214/16]

Written Answers — Department of Social Protection: State Pensions (29 Nov 2016)

Bríd Smith: 353. To ask the Minister for Social Protection if any provision is made or can be made to persons in receipt of a British state old age pension which real value has declined dramatically since Brexit, and that had this pension taken into account during a means test for benefits here. [37646/16]

Written Answers — Department of Arts, Heritage and the Gaeltacht: Post Office Network (29 Nov 2016)

Bríd Smith: 472. To ask the Minister for Arts, Heritage and the Gaeltacht her plans to safeguard the position and operation of the post office network and especially rural post offices; and if she will make a statement on the matter. [32207/16]

Questions on Proposed Legislation (30 Nov 2016)

Bríd Smith: I want to ask about the Planning and Development (Amendment) Bill 2016. We will be debating another aspect of planning and development tomorrow but this Bill relates to the recommendations from the Mahon tribunal. In recommendation No. 9, Mahon recommends that there is a requirement to identify relevant political donations when making planning applications. This is a very urgent issue. We...

Questions on Proposed Legislation (30 Nov 2016)

Bríd Smith: -----that we have the relevant legislation in place that will curtail the brown envelope brigade of both Fianna Fáil and Fine Gael, and their historical legacy.

Questions on Proposed Legislation (30 Nov 2016)

Bríd Smith: Mahon makes that one recommendation. We need to act on it because €150 million of the State's money was spent on getting this recommendation from Mahon and it has not seen the light of day.

Questions on Proposed Legislation (30 Nov 2016)

Bríd Smith: Can we please have it see the light of day before the others return to these Chambers?

Questions on Proposed Legislation (30 Nov 2016)

Bríd Smith: I will not be withdrawing that statement. It is a statement of fact.

Questions on Proposed Legislation (30 Nov 2016)

Bríd Smith: I am very anxious. I am just expressing my anxiety.

Prisons (Solitary Confinement) (Amendment) Bill 2016: Second Stage [Private Members] (1 Dec 2016)

Bríd Smith: Like other Deputies, I warmly welcome this Bill and congratulate Deputy Clare Daly for yet again having the courage to raise a very difficult subject in this Chamber. As she said, we rarely hear any discussion about prisons or prisoners except from the gutter press, which portrays prison life as these people being in some kind of a hotel regime and that, therefore, it is a wonderful place to...

Cannabis for Medicinal Use (Regulations) Bill 2016: Second Stage [Private Members] (1 Dec 2016)

Bríd Smith: I recommend that all Members read the executive summary of the Barnes report from the United Kingdom. I have it here, and it is very interesting. Rather than go through the list of the evidence that it found where cannabis offers potential alleviation from a plethora of medical problems and psychotic problems, I have asked Deputy Gino Kenny to put this executive summary up on his website....

Written Answers — Department of Health: Palliative Care Services (1 Dec 2016)

Bríd Smith: 33. To ask the Minister for Health if his attention has been drawn to the refusal to grant funding for the redevelopment of the palliative care unit in Our Lady's Hospice and Care Unit in Harold's Cross, Dublin 6; and if he will make a statement on the matter. [37961/16]

Written Answers — Department of Health: Medicinal Products Expenditure (1 Dec 2016)

Bríd Smith: 76. To ask the Minister for Health the reason spending on prescribed drugs according to a recent survey here remains extremely high, second only to Germany in the EU, while lifesaving drugs, such as Orkambi for cystic fibrosis, are refused funding due to price gouging by pharmaceutical companies; and if he will make a statement on the matter. [37960/16]